Last checked at 28 May 2020 14:49
UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work
UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Synairgen Share News (SNG)
SNG Share
Price
SNG Share
News
SNG Share
Chat8
SNG Share
Trades15
SNG
Live RNS
SNG Share
Charts
SNG Level 2
Console
SNG Live
Share Price
SNG Broker
Ratings
SNG Directors
Deals
SNG Financial
Diary
SNG
Fundamentals
SNG Short
Positions
SNG
Media
Synairgen Information
Share Price Information for Synairgen (SNG)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
6.64
Bid:
6.00
Ask:
6.98
Change:
-0.38 (-5.41%)
Spread:
0.98 (16.333%)
Open:
6.66
High:
6.66
Low:
6.64
Prev. Close:
7.02
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.26 May 2020 13:55
Synairgen Loss Widens; Progressing On SNG001 Study For Covid-19
Synairgen Loss Widens; Progressing On SNG001 Study For Covid-19
Read more31 Mar 2020 12:21
UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial
UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial
Read more29 Mar 2020 21:00
Sunday share tips: Synairgen, Hollywood Bowl
(Sharecast News) - The Sunday Times's Sabah Meddings recommends buying shares of Synairgen arguing that the Covid-19 pandemic may have given the firm a new lease on life.
Read more29 Mar 2020 20:57
Sunday newspaper round-up: Restrictions, Unemployment, Blood plasma
(Sharecast News) - "Life in Britain will not return to normal for six months, England's deputy chief medical officer has warned, as ministers begin preparing the public for an extended period of lockdown. At the government's daily press conference, Jenny Harries said that strict social distancing rules may have to be in place for between two and three months. But she added that it would be a further three months before all restrictions were lifted, and even then there were likely to be "bumps" as new clusters of cases of coronavirus were identified." - Sunday Times
Read more26 Mar 2020 14:26
UPDATE: Synairgen Successfully Raises Cash For Covid-19 Trials
UPDATE: Synairgen Successfully Raises Cash For Covid-19 Trials
Read more26 Mar 2020 06:58
Synairgen Raises Cash To Go Towards Covid-19 Drug Trial
Synairgen Raises Cash To Go Towards Covid-19 Drug Trial
Read more18 Mar 2020 18:42
Britain's Synairgen gets green light for coronavirus drug trial
By Paul SandleLONDON, March 18 (Reuters) - British pharmaceutical company Synairgen said on Wednesday it had the go-ahead to test a drug that could boost the lung function of patients with coronavirus, potentially assisting in the global fight aga...
Read more18 Mar 2020 16:59
Synairgen Gets Expedited UK Approval To Trial SNG001 For Covid-19
Synairgen Gets Expedited UK Approval To Trial SNG001 For Covid-19
Read more18 Mar 2020 11:17
Synairgen to begin trial of potential Covid-19 therapy
(Sharecast News) - Respiratory drug discovery company Synairgen has received expedited approvals from the Medicines and Healthcare Products Regulatory Agency (MHRA) and Health Research Authority (HRA) to conduct a trial of 'SNG001', an inhaled formulation of interferon-beta-1a, in Covid-19 coronavirus patients, to potentially assist with the global virus pandemic.
Read more1 Oct 2019 13:42
Synairgen Interim Loss Deepens On Costs As Progresses Clinical Trials
Synairgen Interim Loss Deepens On Costs As Progresses Clinical Trials
Read more27 Sep 2019 13:32
Synairgen Expects Positive Outcome From Second Part Of SNG001 Study
Synairgen Expects Positive Outcome From Second Part Of SNG001 Study
Read more24 Jul 2019 12:58
Synairgen Encouraged By Findings So Far In Interferon Beta COPD Study
(Alliance News) - Synairgen PLC on Wednesday said a phase two trial in its inhaled interferon beta programme has found cold and flu infections worsen symptoms for chronic obstructive pulmonary in
Read more9 Jul 2019 09:26
CORRECT (Jul 8): Woodford Transfers Company Stakes After Omnis Departs
(Correcting that Woodford Investment Management transferred a number of stakes following Omnis's decision. It did not sell these stakes, as was originally reported.)(Alliance News) - of
Read more18 Apr 2019 11:52
Synairgen Non-Executive Director Paul Clegg To Retire In June
LONDON (Alliance News) - Synairgen PLC on Thursday said Non-Executive Director Paul Clegg will retire from the company's board after the company's annual general meeting on June Buchanan,
Read more